<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01960894</url>
  </required_header>
  <id_info>
    <org_study_id>Protocol_NIPVA Study_v1_050613</org_study_id>
    <nct_id>NCT01960894</nct_id>
  </id_info>
  <brief_title>Non-invasive Pressure-Volume Analysis (NIPVA)</brief_title>
  <acronym>NIPVA</acronym>
  <official_title>Non-invasive Pressure-Volume Analysis (NIPVA): Extending Comprehensive Left Ventricular Pump Function Assessment to More Patients and Settings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      If the heart fails to pump a sufficient amount of blood, it is crucial to know why in order
      to provide the best treatment. Pressure-volume analysis is the gold standard for evaluating
      the heart's pumping function. Unfortunately, current techniques are invasive, so most
      patients will not get this examination. By combining the strengths of echo-Doppler
      ultrasound, blood pressure monitoring and biomedical computing, the investigators aim to
      develop a non-invasive method for pressure-volume analysis, extending its applicability to
      more patients and settings.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Current methods to evaluate left ventricular (LV) function either are invasive,
      precluding routine use in the majority of patients, or fail to discriminate myocardial,
      hemodynamic and structural factors, rendering assessment imprecise and incomplete.

      Key question: Can we reliably obtain LV functional characteristics by non-invasive means,
      while being able to differentiate more precisely the factors involved? Proposed research: We
      aim to develop a non-invasive method for pressure-volume analysis (NIPVA) of the LV by
      combining echo-Doppler, peripheral blood pressure measurements and biomechanical modelling.
      The validity of this approach will be established by comparison with gold standard invasive
      measurements of pressure-volume relationships in patients undergoing cardiac catheterization.
      Test-retest reproducibility will be also assessed . We hypothesise that NIPVA will provide
      reproducible and valid measures of LV function and be more widely applicable.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2013</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Reproducibility of non-invasive pressure-volume analysis.</measure>
    <time_frame>Immediate</time_frame>
    <description>Reproducibility of test-retest non-invasive pressure-volume analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Agreement between invasive and non-invasive pressure-volume analysis</measure>
    <time_frame>Immediate</time_frame>
    <description>Agreement between invasive and non-invasive pressure-volume analysis</description>
  </primary_outcome>
  <enrollment type="Actual">65</enrollment>
  <condition>Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients attending cardiology out-patient clinics
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals, male or female, aged 18-80 years.

          -  30 patients awaiting elective diagnostic coronary angiography will be recruited.

          -  30 patients attending cardiology out-patient clinics will be recruited.

        Exclusion Criteria:

          -  Patients with atrial fibrillation or other dysrhythmias or those unable to fully
             comply with the protocol will be excluded
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alun Hughes</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Imperial College Healthcare NHS Trust, Hammersmith Hospital</name>
      <address>
        <city>London</city>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <results_reference>
    <citation>Heusinkveld MHG, Delhaas T, Lumens J, Huberts W, Spronck B, Hughes AD, Reesink KD. Augmentation index is not a proxy for wave reflection magnitude: mechanistic analysis using a computational model. J Appl Physiol (1985). 2019 Aug 1;127(2):491-500. doi: 10.1152/japplphysiol.00769.2018. Epub 2019 May 30.</citation>
    <PMID>31161882</PMID>
  </results_reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>October 9, 2013</study_first_submitted>
  <study_first_submitted_qc>October 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 11, 2013</study_first_posted>
  <last_update_submitted>January 17, 2020</last_update_submitted>
  <last_update_submitted_qc>January 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

